Acute interstitial nephritis due to statin and its class effect

Area of Science:

• Nephrology
• Pharmacology
• Internal Medicine

Background:

• Statins are widely prescribed for cholesterol management.
• Emerging evidence suggests potential nephrotoxicity associated with statin use.
• The precise mechanisms underlying statin-induced kidney damage are not fully understood.

Observation:

• A 54-year-old male patient developed acute kidney injury (AKI) after initiating atorvastatin.
• Renal biopsy revealed acute interstitial nephritis as the cause of AKI.
• Discontinuation of atorvastatin and corticosteroid therapy led to renal function recovery.

Findings:

• The patient experienced recurrent AKI upon rechallenge with a different statin, rosuvastatin, after 6 months.
• This recurrence suggests a class effect of statins in causing nephrotoxicity.
• The findings highlight a potential adverse reaction to a common drug class.

Implications:

• Clinicians should be vigilant for potential statin-induced nephrotoxicity, particularly acute interstitial nephritis.
• Consideration of a statin class effect is crucial when evaluating AKI in patients on these medications.
• Further research into the mechanisms of statin nephrotoxicity is warranted to guide safer prescribing practices.